1,004 results match your criteria: "Fujian Medical University Cancer Hospital[Affiliation]"

Expert Consensus on the Diagnosis and Treatment of FGFR Gene-Altered Solid Tumors.

Glob Med Genet

December 2024

Department of Respiratory Medicine, Affiliated Jinling Hospital, Medical School of Nanjing University, Nanjing, Jiangsu, People's Republic of China.

Article Synopsis
  • FGFR is a vital receptor involved in growth and tissue repair, but its gene mutations can lead to cancer by disrupting essential processes.
  • Small molecule drugs and antibodies targeting FGFR mutations, like erdafitinib and pemigatinib, have shown clinical efficacy in treating certain cancer types.
  • Effective screening methods for FGFR variants are essential for utilizing FGFR inhibitors in treatment, and a consensus has been developed to standardize diagnosis and treatment processes.
View Article and Find Full Text PDF

To assess the cost-effectiveness of treating invasive aspergillosis with isavuconazole, posaconazole and voriconazole in China. A cost-consequence analysis (CCA) was conducted, considering both healthcare system and patient out-of-pocket perspectives. We considered the costs of medications, diagnostics and hospitalization and the consequences of mortality, response rate and adverse events.

View Article and Find Full Text PDF

Bulk- and single cell-RNA sequencing reveal KIF20A as a key driver of hepatocellular carcinoma progression and immune evasion.

Front Immunol

November 2024

Department of Radiation Oncology, Jiangxi Clinical Research Center for Cancer, Jiangxi Cancer Hospital, The Second Affiliated Hospital of Nanchang Medical College, Nanchang, Jiangxi, China.

Introduction: Kinesin family member 20A (KIF20A) is essential for cell proliferation and is implicated in promoting tumor progression, but its role in hepatocellular carcinoma (HCC) remains poorly studied.

Methods: Through the analysis of bulk RNA-sequencing (bulk RNA-seq) and single-cell RNA sequencing (scRNA-seq) data, the expression of KIF20A and its relationship with diagnosis, prognosis, and the immune microenvironment were examined. The association between KIF20A and the malignant progression and metastasis of HCC was confirmed through and experiments.

View Article and Find Full Text PDF

Few biomarkers are available for predicting chemotherapeutic response and prognosis in colorectal cancer (CRC). Long-noncoding RNAs (lncRNAs) are essential for CRC development and growth. Therefore, studying lncRNAs may reveal potential predictors of chemotherapy response and prognosis in CRC.

View Article and Find Full Text PDF

Expert consensus on the diagnosis and treatment of solid tumors with BRAF mutations.

Innovation (Camb)

November 2024

Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Melanoma and Sarcoma, Peking University Cancer Hospital & Institute, Beijing 100142, P.R. China.

Article Synopsis
  • * BRAF mutations are common in various cancers, and targeted therapies, especially BRAF inhibitors like dabrafenib and trametinib, are developed for treating solid tumors with these mutations.
  • * An expert consensus has been established to improve the diagnosis and treatment of solid tumors with BRAF mutations, focusing on summarizing their clinical features, recommending genetic testing methods, and creating a systematic approach for patient care.
View Article and Find Full Text PDF
Article Synopsis
  • Cuprotosis, a new type of cell death, is regulated by ferredoxin 1 (FDX1), which was analyzed in a study involving multiple cancer types to assess its prognostic implications and predictive models using imaging data.
  • The research utilized a large dataset of cancer cases and imaging techniques, employing methods like feature extraction and logistic regression to create radiomic models aimed at predicting FDX1 expression.
  • Results indicated that FDX1 could effectively predict patient outcomes across various cancers, with a promising predictive accuracy, highlighting its potential as a non-invasive biomarker for clinical use and its relevance to immunosuppressive factors.
View Article and Find Full Text PDF

Following the publication of the 2021 WHO Classification of Central Nervous System Tumors (CNS5), Following the publication of the 2021 WHO Classification of Central Nervous System Tumors (CNS5), prognostic markers of glioblastoma (GBM) need to be further explored. Radiomics is a non-invasive and reproducible method for the prognostic assessment of multiple solid tumors. This study aimed to explore the prognostic value and biological significance of MRI T1-weighted enhancement (CE-T1) based radiomics in GBM (CNS5).

View Article and Find Full Text PDF

Background: Postoperative radiotherapy (PORT) is crucial for patients with thoracic locally advanced esophageal squamous cell carcinoma (LA-ESCC, pT3-4aN0-3M0) following esophagectomy. However, the appropriate radiation volume has not been well established. This study aimed to determine the optimal PORT volume for LA-ESCC patients.

View Article and Find Full Text PDF
Article Synopsis
  • - The study developed and validated a nomogram—a personalized treatment tool—for adenoid cystic carcinoma of the head and neck using data from 1,069 patients diagnosed between 2004 and 2015 in the SEER database.
  • - Key factors like age, tumor site, and TNM stages were identified as significant predictors of patient outcomes through advanced statistical analyses.
  • - The nomogram outperformed traditional TNM staging in predicting survival, helping to categorize patients into high-risk and low-risk groups for more tailored treatment plans.
View Article and Find Full Text PDF

Phase II study of enlonstobart (SG001), a novel PD-1 inhibitor in patients with PD-L1 positive recurrent/metastatic cervical cancer.

Gynecol Oncol

December 2024

Department of Gynecology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China. Electronic address:

Background: Platinum-based chemotherapy with or without bevacizumab is the first-line treatment for patients with recurrent or metastatic cervical cancer (r/mCC), and the treatment options are limited for r/mCC after first-line treatment. Enlonstobart (SG001) is a fully humanized and high-affinity anti-PD-1 immunoglobulin G4 monoclonal antibody. Previous phase Ib study demonstrated that SG001 had a promising efficacy in patients with PD-L1 positive r/mCC.

View Article and Find Full Text PDF

First-line zorifertinib for EGFR-mutant non-small cell lung cancer with central nervous system metastases: The phase 3 EVEREST trial.

Med

October 2024

Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, Guangdong 510080, China. Electronic address:

Article Synopsis
  • Zorifertinib is an experimental cancer drug that targets mutations in the EGFR gene and has shown effectiveness in patients with lung cancer that has spread to the brain.
  • A phase 3 trial compared zorifertinib to standard treatments and found that it significantly extended the time patients lived without the disease worsening (progression-free survival).
  • Results indicate that zorifertinib may be a better first-line treatment option for non-small cell lung cancer due to its ability to improve survival and manage side effects effectively.
View Article and Find Full Text PDF
Article Synopsis
  • HBM4003 is a new heavy chain-only antibody designed to work with anti-PD-1 antibody toripalimab, aiming to treat advanced solid tumors like melanoma while maintaining safety.* -
  • In a phase I trial involving 40 patients, 90% experienced some treatment-related adverse events, but no severe complications (grade 4 or 5) were reported; the treatment showed varying efficacy based on prior PD-1 treatment.* -
  • Results indicated an objective response rate of 33.3% for treatment-naïve melanoma patients, and baseline Treg/CD4+ ratio was identified as a potential predictor of treatment efficacy.*
View Article and Find Full Text PDF

Federated learning via multi-attention guided UNet for thyroid nodule segmentation of ultrasound images.

Neural Netw

January 2025

National-Regional Key Technology Engineering Laboratory for Medical Ultrasound, Guangdong Key Laboratory for Biomedical Measurements and Ultrasound Imaging, School of Biomedical Engineering, Health Science Centre, Shenzhen University, Shenzhen, PR China. Electronic address:

Article Synopsis
  • - The multi-attention guided UNet (MAUNet) is proposed for improved segmentation of thyroid nodules, addressing challenges due to their varying sizes and positions using a multi-scale cross attention (MSCA) module for better feature extraction.
  • - A dual attention (DA) module enhances information sharing between the encoder and decoder in the UNet architecture, further refining segmentation results.
  • - Extensive tests on ultrasound images from 17 hospitals reveal that MAUNet achieves high Dice scores (around 0.9) and outperforms existing segmentation methods, demonstrating effective generalization across diverse datasets while maintaining patient privacy through federal learning.
View Article and Find Full Text PDF

Objectives: To investigate the correlation of the mitotic index (MI) of 1-5 cm gastric gastrointestinal stromal tumors (gGISTs) with CT-identified morphological and first-order radiomics features, incorporating subgroup analysis based on tumor size.

Methods: We enrolled 344 patients across four institutions, each pathologically diagnosed with 1-5 cm gGISTs and undergoing preoperative contrast-enhanced CT scans. Univariate and multivariate analyses were performed to investigate the independent CT morphological high-risk features of MI.

View Article and Find Full Text PDF

High buttocks supine position to reduce small bowel exposure in gynecological radiotherapy.

Radiat Oncol

September 2024

Department of Radiation Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, China.

Article Synopsis
  • The study aimed to reduce radiation exposure to the small bowel in women receiving radiation therapy for gynecological tumors by using a specific body positioning technique.
  • The research involved 76 patients, with 36 using a raised buttocks position and 40 in a standard supine position, leading to a significant decrease in the irradiated small bowel volume in the trial group.
  • Results indicated that the effective positioning not only minimized radiation exposure to the small bowel without bladder distension but also showed potential benefits for treating various pelvic tumors.
View Article and Find Full Text PDF
Article Synopsis
  • Neoadjuvant radiotherapy is the standard treatment for locally advanced rectal cancer, but its effectiveness varies among patients, prompting the need for personalized treatment approaches based on molecular signatures.
  • The study aimed to develop and validate a genome-based model (GARD) for determining radiation doses in these patients by analyzing gene expression from tumors collected from 64 patients undergoing treatment between 2015 and 2018.
  • Results indicated significant differences in treatment response, with a median NAR score of 8.43 demonstrating the variability in clinical efficacy among patients with similar tumor stages, highlighting the potential for tailored radiation therapy.
View Article and Find Full Text PDF

Identification of a ferroptosis-related gene signature for the prognosis of pediatric neuroblastoma.

Transl Cancer Res

July 2024

Department of Radiation Oncology, Fujian Children's Hospital (Fujian Branch of Shanghai Children's Medical Center), College of Clinical Medicine for Obstetrics & Gynecology and Pediatrics, Fujian Medical University, Fuzhou, China.

Background: Ferroptosis-related genes are correlated with the prognosis of patients with neuroblastoma (NB) remains unknown. This study aims to establish a prognostic ferroptosis-related gene model for predicting prognostic value in pediatric NB patients.

Methods: The gene expression array and clinical characteristics of NB were downloaded from a public database.

View Article and Find Full Text PDF

Objective: This study aimed to develop and validate a survival prediction model and nomogram to predict survival in patients with advanced gastric or gastroesophageal junction (G/GEJ) adenocarcinoma undergoing treatment with anti-programmed cell death 1 receptor (PD-1). This model incorporates immune-related adverse events (irAEs) alongside common clinical characteristics as predictive factors.

Method: A dataset comprising 255 adult patients diagnosed with advanced G/GEJ adenocarcinoma was assembled.

View Article and Find Full Text PDF

Objective: To assess the infiltration characteristics of tumour-associated macrophages (TAMs) in buccal mucosa carcinoma (BMC) and the correlation of these features with clinicopathological factors.

Materials And Methods: Immunohistochemistry was used to detect the expression of TAM-related markers (CD68, CD163, CD206), CD8+ T cell markers, PD-L1, and epidermal growth factor receptor (EGFR) in 46 patients with mucosal cancer after radical surgery. In addition, the correlation between TAM infiltration and clinical characteristics, PD-L1 expression, and EGFR expression was analysed.

View Article and Find Full Text PDF

Vebreltinib for Advanced Non-Small Cell Lung Cancer Harboring c-Met Exon 14 Skipping Mutation: A Multicenter, Single-Arm, Phase II KUNPENG Study.

J Clin Oncol

November 2024

Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital and Guangdong Academy of Medical Sciences, Southern Medical University, Guangzhou, China.

Purpose: The KUNPENG study aimed to evaluate the efficacy and safety of vebreltinib (also known as bozitinib, APL-101, PLB-1001, and CBT-101), a potent and highly selective inhibitor of c-mesenchymal-epithelial transition (), in patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) harboring c-Met alterations.

Methods: This multicenter, multicohort, open-label, single-arm, phase II trial enrolled patients with c-Met dysregulated, locally advanced or metastatic NSCLC from January 2020 to August 2022 across 17 centers. Cohort 1 included patients with exon 14 skipping (ex14)-mutant NSCLC who had not previously received inhibitors.

View Article and Find Full Text PDF

Background: The significant expression of PD-L1 in thymic epithelial tumors (TETs) has been confirmed, and immunotherapy and its combination therapy have been effective in TETs. However, there is no present evidence that the expression levels of PD-L1 affects the efficacy of combination therapy. Our study aimed to shed light on this relationship.

View Article and Find Full Text PDF

Real-world data on ALK rearrangement test in Chinese advanced non-small cell lung cancer (RATICAL): a nationwide multicenter retrospective study.

Cancer Commun (Lond)

September 2024

Department of Pathology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, P. R. China.

Background: Anaplastic lymphoma kinase (ALK) test in advanced non-small cell lung cancer (NSCLC) can help physicians provide target therapies for patients harboring ALK gene rearrangement. This study aimed to investigate the real-world test patterns and positive rates of ALK gene rearrangements in advanced NSCLC.

Methods: In this real-world study (ChiCTR2000030266), patients with advanced NSCLC who underwent an ALK rearrangement test in 30 medical centers in China between October 1, 2018 and December 31, 2019 were retrospectively analyzed.

View Article and Find Full Text PDF

Automated segmentation of brain metastases with deep learning: A multi-center, randomized crossover, multi-reader evaluation study.

Neuro Oncol

November 2024

State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guang zhou, Guangdong Province, China.

Background: Artificial intelligence has been proposed for brain metastasis (BM) segmentation but it has not been fully clinically validated. The aim of this study was to develop and evaluate a system for BM segmentation.

Methods: A deep-learning-based BM segmentation system (BMSS) was developed using contrast-enhanced MR images from 488 patients with 10338 brain metastases.

View Article and Find Full Text PDF

HNF1ɑ promotes colorectal cancer progression via HKDC1-mediated activation of AKT/AMPK signaling pathway.

Gene

November 2024

Department of Colorectal Surgery, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, Fujian 350014, China; Fujian Medical University, Fuzhou, Fujian 350122, China; Fujian Provincial Key Laboratory of Tumor Biotherapy, Fujian Cancer Hospital, Fujian Medical University Cancer Hospital, Fuzhou 350014, China. Electronic address:

The hepatocyte nuclear factor-1 (HNF1ɑ) is a transcription factor that contributes to several kinds of cancer progression. However, very little is known regarding the mechanisms underlying the activity of HNF1ɑ. We aimed to explore the role of HNF1ɑ in the progress of colorectal cancer (CRC) and elucidate its molecular mechanism.

View Article and Find Full Text PDF